Hjem › Mage-tarmstromale tumorer › Michigan
Kliniske studier for Mage-tarmstromale tumorer i Michigan
7 studier for Mage-tarmstromale tumorer søker deltakere på steder i Michigan.
Byer i Michigan
Offisiell studietekst (engelsk)
A Study of IDRX-42 (GSK6042981) Versus (vs) Sunitinib in Participants With Gastrointestinal Stromal Tumors After Imatinib Therapy
- GSK Investigational Site, Ann Arbor
RekruttererFase 3
Alder 18 og eldre · Alle kjønn · Oppdatert 5. okt. 2026 · NCT07218926A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)
- Profound Research -OMG - TriAtria Cancer Center, Farmington Hills
RekruttererFase 2
Alder 18 og eldre · Alle kjønn · Oppdatert 2. okt. 2026 · NCT06760819KQB198 in Combination With Imatinib in Participants With Advanced/Metastatic GIST in 1st Line Setting (SynerGIST-1st Line)
- University of Michigan Hospitals, Ann Arbor
RekruttererFase 2
Alder 18 og eldre · Alle kjønn · Oppdatert 10. aug. 2026 · NCT07406633A Study of Inlexisertib (DCC-3116) in Combination With Anticancer Therapies in Participants With Advanced Malignancies
- START Midwest, Grand Rapids
RekruttererFase 1/2
Alder 18 og eldre · Alle kjønn · Oppdatert 23. jul. 2026 · NCT05957367A Study of Ziftomenib in Combination With Imatinib in Patients With Advanced Gastrointestinal Stromal Tumors (GIST)
- University of Michigan, Ann Arbor
RekruttererFase 1
Alder 18 og eldre · Alle kjønn · Oppdatert 5. feb. 2026 · NCT06655246A Master Protocol to Evaluate DCC-3009 in Gastrointestinal Stromal Tumor (GIST)
- START Midwest, Grand Rapids
RekruttererFase 1/2
Alder 18 og eldre · Alle kjønn · Oppdatert 5. feb. 2026 · NCT06630234A Study of the c-Kit Specific Antibody-Drug Conjugate NN3201 for Advanced and/or Metastatic Solid Tumors Known to Express c-Kit
- University of Michigan Hospitals, Ann Arbor
RekruttererFase 1
Alder 18 og eldre · Alle kjønn · Oppdatert 23. sep. 2025 · NCT06805825Fra ClinicalTrials.gov, data hentet 6. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.